Ac immune on track to meet five clinical milestones expected in 2020

Ac immune reports q1 2020 financial results and provides business update.on track to meet five clinical milestones expected in 2020 with no modifying guidance as a result of covid-19.qtrly revenue totaled chf 12.4 million, a chf 62.6 million decrease.as of march 31, had a total cash balance of chf 277.9 million.qtrly loss per share chf 0.11.qtrly adjusted loss per share chf 0.09.is fully financed through q1 2024, excluding potential incoming milestones.q1 earnings per share view chf -0.14, revenue view chf 12.9 million -- refinitiv ibes data.
ACIU Ratings Summary
ACIU Quant Ranking